Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? J Neuroimmune Pharmacol. 2020 06; 15(2):174-180.

View in: PubMed